Glaxosmithkline | GSK - Loan Capital

Stock Price
54.49
Daily Change
-4.63 -7.83%
Monthly
-8.05%
Yearly
39.83%
Q2 Forecast
53.52

Glaxosmithkline reported GBP19.82B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Amgen USD 50B 2.43B Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Aurora Cannabis CAD 33.2M 1.79M Dec/2025
Bausch Health Companies USD 20.62B 152M Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Canopy Growth CAD 224.99M 1.34M Dec/2025
Drreddys Laboratories INR 129.19M 1.84M Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Glaxosmithkline GBP 19.82B 203.13M Dec/2025
J&J USD 37.53B 1.91B Mar/2026
Merck USD 39.97B 6B Sep/2025
Novartis USD 29.59B 5.35B Dec/2025
Pacira USD 372.19M 4.53M Dec/2025
Perrigo USD 3.6B 4.5M Dec/2025
Pfizer USD 57.41B 93M Sep/2025
Phibro Animal Health USD 603.6M 5.92M Dec/2025
Prestige Brands USD 1.05B 39.73M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Takeda JPY 4.27T 81.29B Dec/2025
Teva Pharmaceutical Industries USD 14.99B 1.78B Dec/2025
Zoetis USD 9.04B 1.97B Dec/2025